Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - The Campylobacter jejuni cell membrane protects against the bactericidal activity of human breastmilk

ABSTRACT: Lipidomic analysis of C. jejuni strains evolved to grow in human breastmilk.

INSTRUMENT(S): ACQUITY UPLC I-Class, Synapt XS

ORGANISM(S): Campylobacter Jejuni (ncbitaxon:197)

SUBMITTER: Christine Szymanski Kelly M. Hines

PROVIDER: MSV000094612 | GNPS | Wed Apr 24 11:47:00 BST 2024

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

The Campylobacter jejuni cell membrane protects against the bactericidal activity of human breastmilk

Project description:Lipidomic analysis of C. jejuni strains evolved to grow in human breastmilk.

2024-04-24 | MSV000094612 | MassIVE

Systemwide effects of ER-intracellular membrane contact site disturbance in primary endothelial cells

Project description:We investigate how the double knock down of VAPA and VAPB affected the macromolecule profile of human umbilical vein endothelial cells by transcriptomic and lipidomic profiling

2023-06-28 | GSE227477 | GEO

Transcriptomic analysis of evolved strains.

Project description:Transcriptomic analysis of evolved strains.

| PRJNA680702 | ENA

Project description:Evolved strains sequencing

| PRJNA936493 | ENA

Carvacrol exhibits rapid bactericidal activity against Streptococcus pyogenes through cell membrane damage.

Project description:Streptococcus pyogenes is an important human pathogen worldwide. The identification of natural antibacterial phytochemicals has renewed interest due to the current scarcity of antibiotic development. Carvacrol is a monoterpenoid found in herbs. We evaluated carvacrol alone and combined with selected antibiotics against four strains of S. pyogenes in vitro. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of carvacrol against S. pyogenes were 125 µg/mL (0.53 mM) and 250 µg/mL (1.05 mM), respectively. Kill curve results showed that carvacrol exhibits instantaneous bactericidal activity against S. pyogenes. We also demonstrated the potential mechanism of action of carvacrol through compromising the cell membrane integrity. Carvacrol induced membrane integrity changes leading to leakage of cytoplasmic content such as lactate dehydrogenase enzymes and nucleic acids. We further confirmed dose-dependent rupturing of cells and cell deaths using transmission electron microscopy. The chequerboard assay results showed that carvacrol possesses an additive-synergistic effect with clindamycin or penicillin. Carvacrol alone, combined with clindamycin or penicillin, can be used as a safe and efficacious natural health product for managing streptococcal pharyngitis.

| S-EPMC7811018 | biostudies-literature

Polyploidy can drive rapid adaptation in yeast

Project description:Analysis of copy number variation in evolved haploid, diploid, tetraploid strains.

2015-02-28 | GSE51017 | GEO

kcat_estimation_quantitative_Proteomics

Project description:Label-free quantitative proteomic analysis of laboratory-evolved E. coli strains.

| MSV000084301 | MassIVE

Project description:Evolved Bacillus subtilis strains

| PRJNA1031373 | ENA

Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane.

Project description:Glioblastoma (GB) is a histological and genetically heterogeneous brain tumor that is highly proliferative and vascularized. The prognosis is poor with currently available treatment. In this study, we evaluated the cytotoxicity and antiangiogenic activity of doxorubicin-loaded-chitosan-coated-arginylglycylaspartic acid-functionalized-poly(ε-caprolactone)-alpha bisabolol-LNC (AB-DOX-LNC-L-C-RGD). The nanoformulation was prepared by self-assembling followed by interfacial reactions, physicochemically characterized and evaluated in vitro against GB cell lines (U87MG and U138MG) and in vivo using the chicken chorioallantoic membrane assay (CAM). Spherical shape nanocapsules had a hydrodynamic mean diameter of 138 nm, zeta potential of +13.4 mV, doxorubicin encapsulation of 65%, and RGD conjugation of 92%. After 24 h of treatment (U87MG and U138MG), the median inhibition concentrations (IC50) were 520 and 490 nmol L-1 doxorubicin-equivalent concentrations, respectively. The treatment induced antiproliferative activity with S-phase cell-cycle arrest and apoptosis in the GB cells. Furthermore, after 48 h of exposure, evaluation of antiangiogenic activity (CAM) showed that the relative vessel growth following treatment with the nanocapsules was 5.4 times lower than that with the control treatment. The results support the therapeutic potential of the nanoformulation against GB and, thereby, pave the way for future preclinical studies.

| S-EPMC8230781 | biostudies-literature

Harzianic acid exerts antimicrobial activity against Gram-positive bacteria and targets the cell membrane.

Project description:The thermophilic fungus Oidiodendron flavum is a saprobe that is commonly isolated from soil. Here, we identified a Gram-positive bacteria-selective antimicrobial secondary metabolite from this fungal species, harzianic acid (HA). Using Bacillus subtilis strain 168 combined with dynamic bacterial morphology imaging, we found that HA targeted the cell membrane. To further study the antimicrobial activity of HA, we isolated an HA-resistant strain, Bacillus subtilis strain M9015, and discovered that the mutant had more translucent colonies than the wild type strain, showed cross resistance to rifampin, and harbored five mutations in the coding region of four distinct genes. Further analysis of these genes indicated that the mutation in atpE might be responsible for the translucency of the colonies, and mutation in mdtR for resistance to both HA and rifampin. We conclude that HA is an antimicrobial agent against Gram-positive bacteria that targets the cell membrane.

| S-EPMC10860749 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data